vs
Side-by-side financial comparison of BillionToOne, Inc. (BLLN) and LIVEPERSON INC (LPSN). Click either name above to swap in a different company.
BillionToOne, Inc. is the larger business by last-quarter revenue ($83.5M vs $59.3M, roughly 1.4× LIVEPERSON INC). BillionToOne, Inc. runs the higher net margin — 6.8% vs -77.8%, a 84.6% gap on every dollar of revenue. On growth, BillionToOne, Inc. posted the faster year-over-year revenue change (117.4% vs -19.0%). BillionToOne, Inc. produced more free cash flow last quarter ($6.5M vs $-12.0M).
BillionToOne, Inc. is a life sciences and molecular diagnostics firm developing high-precision genetic testing solutions. Its core offerings include non-invasive prenatal tests, oncology diagnostics, and rare disease screening, serving clinical providers and patients mainly in North America.
LivePerson is a global technology company that develops conversational commerce and AI software.
BLLN vs LPSN — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $83.5M | $59.3M |
| Net Profit | $5.7M | $-46.1M |
| Gross Margin | 69.9% | 73.2% |
| Operating Margin | 11.5% | -68.7% |
| Net Margin | 6.8% | -77.8% |
| Revenue YoY | 117.4% | -19.0% |
| Net Profit YoY | 138.3% | 58.9% |
| EPS (diluted) | $0.10 | $-9.22 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $59.3M | ||
| Q3 25 | $83.5M | $60.2M | ||
| Q2 25 | — | $59.6M | ||
| Q1 25 | — | $64.7M | ||
| Q4 24 | $45.1M | $73.2M | ||
| Q3 24 | $38.4M | $74.2M | ||
| Q2 24 | — | $79.9M | ||
| Q1 24 | — | $85.1M |
| Q4 25 | — | $-46.1M | ||
| Q3 25 | $5.7M | $8.7M | ||
| Q2 25 | — | $-15.7M | ||
| Q1 25 | — | $-14.1M | ||
| Q4 24 | $-11.5M | $-112.1M | ||
| Q3 24 | $-14.9M | $-28.3M | ||
| Q2 24 | — | $41.8M | ||
| Q1 24 | — | $-35.6M |
| Q4 25 | — | 73.2% | ||
| Q3 25 | 69.9% | 71.4% | ||
| Q2 25 | — | 69.7% | ||
| Q1 25 | — | 71.8% | ||
| Q4 24 | 57.1% | 77.4% | ||
| Q3 24 | 52.6% | 73.1% | ||
| Q2 24 | — | 79.4% | ||
| Q1 24 | — | 71.3% |
| Q4 25 | — | -68.7% | ||
| Q3 25 | 11.5% | -24.2% | ||
| Q2 25 | — | -10.8% | ||
| Q1 25 | — | -26.2% | ||
| Q4 24 | 17.0% | -138.0% | ||
| Q3 24 | -32.9% | -21.6% | ||
| Q2 24 | — | -37.3% | ||
| Q1 24 | — | -42.7% |
| Q4 25 | — | -77.8% | ||
| Q3 25 | 6.8% | 14.5% | ||
| Q2 25 | — | -26.4% | ||
| Q1 25 | — | -21.8% | ||
| Q4 24 | -25.5% | -153.2% | ||
| Q3 24 | -38.8% | -38.1% | ||
| Q2 24 | — | 52.3% | ||
| Q1 24 | — | -41.8% |
| Q4 25 | — | $-9.22 | ||
| Q3 25 | $0.10 | $-2.76 | ||
| Q2 25 | — | $-0.17 | ||
| Q1 25 | — | $-0.24 | ||
| Q4 24 | $-1.13 | $-17.23 | ||
| Q3 24 | $-1.47 | $-4.74 | ||
| Q2 24 | — | $-0.33 | ||
| Q1 24 | — | $-0.40 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $195.2M | $95.0M |
| Total DebtLower is stronger | $55.0M | — |
| Stockholders' EquityBook value | $-239.5M | $-44.5M |
| Total Assets | $327.5M | $454.7M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $95.0M | ||
| Q3 25 | $195.2M | $106.7M | ||
| Q2 25 | — | $162.0M | ||
| Q1 25 | — | $176.3M | ||
| Q4 24 | $191.5M | $183.2M | ||
| Q3 24 | — | $142.1M | ||
| Q2 24 | — | $146.0M | ||
| Q1 24 | — | $127.1M |
| Q4 25 | — | — | ||
| Q3 25 | $55.0M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $51.5M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $512.1M |
| Q4 25 | — | $-44.5M | ||
| Q3 25 | $-239.5M | $-22.1M | ||
| Q2 25 | — | $-82.4M | ||
| Q1 25 | — | $-74.9M | ||
| Q4 24 | $-251.7M | $-67.3M | ||
| Q3 24 | $-242.9M | $45.9M | ||
| Q2 24 | — | $66.6M | ||
| Q1 24 | — | $19.2M |
| Q4 25 | — | $454.7M | ||
| Q3 25 | $327.5M | $511.4M | ||
| Q2 25 | — | $604.2M | ||
| Q1 25 | — | $596.2M | ||
| Q4 24 | $302.1M | $607.8M | ||
| Q3 24 | — | $692.0M | ||
| Q2 24 | — | $703.8M | ||
| Q1 24 | — | $724.7M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 26.69× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $13.8M | $-9.7M |
| Free Cash FlowOCF − Capex | $6.5M | $-12.0M |
| FCF MarginFCF / Revenue | 7.7% | -20.2% |
| Capex IntensityCapex / Revenue | 8.8% | 3.9% |
| Cash ConversionOCF / Net Profit | 2.42× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-42.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-9.7M | ||
| Q3 25 | $13.8M | $-6.0M | ||
| Q2 25 | — | $-11.7M | ||
| Q1 25 | — | $-3.1M | ||
| Q4 24 | — | $-3.1M | ||
| Q3 24 | — | $4.8M | ||
| Q2 24 | — | $-17.9M | ||
| Q1 24 | — | $1.1M |
| Q4 25 | — | $-12.0M | ||
| Q3 25 | $6.5M | $-8.9M | ||
| Q2 25 | — | $-14.8M | ||
| Q1 25 | — | $-6.9M | ||
| Q4 24 | — | $-6.8M | ||
| Q3 24 | — | $-230.0K | ||
| Q2 24 | — | $-22.9M | ||
| Q1 24 | — | $-10.4M |
| Q4 25 | — | -20.2% | ||
| Q3 25 | 7.7% | -14.8% | ||
| Q2 25 | — | -24.9% | ||
| Q1 25 | — | -10.6% | ||
| Q4 24 | — | -9.2% | ||
| Q3 24 | — | -0.3% | ||
| Q2 24 | — | -28.7% | ||
| Q1 24 | — | -12.2% |
| Q4 25 | — | 3.9% | ||
| Q3 25 | 8.8% | 4.8% | ||
| Q2 25 | — | 5.3% | ||
| Q1 25 | — | 5.8% | ||
| Q4 24 | — | 5.0% | ||
| Q3 24 | — | 6.8% | ||
| Q2 24 | — | 6.2% | ||
| Q1 24 | — | 13.5% |
| Q4 25 | — | — | ||
| Q3 25 | 2.42× | -0.69× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -0.43× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BLLN
| Prenatal | $74.1M | 89% |
| Oncology | $8.7M | 10% |
LPSN
| Hosted Services Business | $51.0M | 86% |
| Professional Services | $8.3M | 14% |
